Identification of a Chlorogenic Ester as a Monoamine Oxidase (MAO-B) Inhibitor by Integrating “Traditional and Machine Learning” Virtual Screening and In Vitro as well as In Vivo Validation: A Lead against Neurodegenerative Disorders?-Reference-Cited by-同舟云学术

Identification of a Chlorogenic Ester as a Monoamine Oxidase (MAO-B) Inhibitor by Integrating “Traditional and Machine Learning” Virtual Screening and In Vitro as well as In Vivo Validation: A Lead against Neurodegenerative Disorders?

Published:2021-09-23 Issue:19 Volume:12 Page:3690-3707
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Dhanabalan Anantha Krishnan¹^ORCID,Subaraja Mamangam²,Palanichamy Kuppusamy¹,Velmurugan Devadasan¹,Gunasekaran Krishnasamy¹³

Affiliation:

1. Centre of Advanced Study in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai 600025, Tamil Nadu, India

2. Vivekanandha College of Arts and Sciences for Women (Autonomous), Tiruchengode 637205, Tamil Nadu, India

3. Bioinformatics Infrastructure Facility, University of Madras, Guindy Campus, Chennai 600025, Tamil Nadu, India

Funder

Indian Council of Medical Research

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.1c00430

Reference82 articles.

1. Molecular Dynamics, Flexible Docking, Virtual Screening, ADMET Predictions, and Molecular Interaction Field Studies to Design Novel Potential MAO-B Inhibitors

2. Structural Comparison of Human Monoamine Oxidases A and B

3. MONOAMINE OXIDASE: From Genes to Behavior

4. The therapeutic potential of monoamine oxidase inhibitors

5. Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionation;Acta Pharmaceutica Sinica B;2024-04

2. Molecular Docking for Virtual Screening of Potential Active Ingredients in Chinese Medicines;Quality Control of Chinese Medicines;2024

3. Monoamine Oxidases and Flavin-Containing Monooxygenases;Reference Module in Biomedical Sciences;2024

4. Targeting Monoamine Oxidase B for the Treatment of Alzheimer’s and Parkinson’s Diseases Using Novel Inhibitors Identified Using an Integrated Approach of Machine Learning and Computer-Aided Drug Design;Mathematics;2023-03-17

5. Biological activity evaluation of novel monoamine oxidase inhibitory compounds targeting Parkinson disease;Future Medicinal Chemistry;2022-11